![Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function - ScienceDirect Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109721000140-fx1.jpg)
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function - ScienceDirect
![Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction - Packer - 2021 - European Journal of Heart Failure - Wiley Online Library Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction - Packer - 2021 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7be14815-0501-4c5f-aefa-e2a97c4e7cbc/ejhf2149-toc-0001-m.jpg)
Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction - Packer - 2021 - European Journal of Heart Failure - Wiley Online Library
![Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction | Journal of the American Heart Association Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/55470a3e-323c-4eeb-84e3-793de6792c53/jah34641-fig-0001.png)
Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction | Journal of the American Heart Association
![Spironolactone 50 Mg, Capacity: Usual Dose Is 100-200Mg/Day, Packaging Size: 15 Tablets in 1 Stripe at Rs 55/stripe in Mumbai Spironolactone 50 Mg, Capacity: Usual Dose Is 100-200Mg/Day, Packaging Size: 15 Tablets in 1 Stripe at Rs 55/stripe in Mumbai](https://5.imimg.com/data5/SELLER/Default/2022/9/ZN/OQ/GL/159422374/spironolactone-50-mg-500x500.webp)
Spironolactone 50 Mg, Capacity: Usual Dose Is 100-200Mg/Day, Packaging Size: 15 Tablets in 1 Stripe at Rs 55/stripe in Mumbai
![PDF] Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). | Semantic Scholar PDF] Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d023387aff06eda615ab4b6ca59359179dce12f2/3-Table2-1.png)
PDF] Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). | Semantic Scholar
![Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries | Journal of the American Heart Association Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/bb876ed6-d858-4d64-ac52-2f8ccd6d0828/jah33625-fig-0001.png)
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries | Journal of the American Heart Association
![Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial - The Lancet Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial - The Lancet](https://www.thelancet.com/cms/attachment/92c78bdc-c776-4547-8c9f-25d568de4172/gr1_lrg.gif)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial - The Lancet
![Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: Putting Guidelines into Practice — INTRODUCTION. - ppt download Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: Putting Guidelines into Practice — INTRODUCTION. - ppt download](https://images.slideplayer.com/15/4800595/slides/slide_46.jpg)
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: Putting Guidelines into Practice — INTRODUCTION. - ppt download
![Potential effect of spironolactone in prevention of pulmonary fibrosis.... | Download Scientific Diagram Potential effect of spironolactone in prevention of pulmonary fibrosis.... | Download Scientific Diagram](https://www.researchgate.net/publication/348558076/figure/fig1/AS:980981666291718@1610895663874/Potential-effect-of-spironolactone-in-prevention-of-pulmonary-fibrosis-MCP-1-monocyte.png)
Potential effect of spironolactone in prevention of pulmonary fibrosis.... | Download Scientific Diagram
![Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization - ScienceDirect Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177918304670-fx1.jpg)